In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!
Session

Event : ESC Congress 2018

Topic : Clinical Skills

  • Session type : Satellite Symposium
  • Date : 28 August 2018
  • Time : 13:00 - 14:00
  • Sponsored by Amgen Europe GmbH

4 presentations in this session

Introduction - Treatment of ischemic heart disease patients in 2018

Event : ESC Congress 2018

  • Session : LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!
  • Speaker : U Landmesser (Berlin,DE)
  • Sponsored by Amgen Europe GmbH

What approach to CV risk management in 2018?

Event : ESC Congress 2018

  • Session : LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!
  • Speaker : KK Ray (London,GB)
  • Sponsored by Amgen Europe GmbH

Where PCSK9 inhibitors can make a difference

Event : ESC Congress 2018

  • Session : LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!
  • Speaker : C Ballantyne (Houston,US)
  • Sponsored by Amgen Europe GmbH

Panel discussion and wrap-up - LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!

Event : ESC Congress 2018

  • Session : LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!
  • Speaker : U Landmesser (Berlin,DE), C Ballantyne (Houston,US), KK Ray (London,GB)
  • Sponsored by Amgen Europe GmbH

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are